AlloVir, Inc.
ALVR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $183,464 | $183,460 | $48,679 | $47,935 |
| - Cash | $42,387 | $88,426 | $100,965 | $118,289 |
| + Debt | $1,545 | $0 | $0 | $0 |
| Enterprise Value | $142,622 | $95,034 | -$52,286 | -$70,354 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$11,894 | -$12,256 | -$10,354 | -$19,195 |
| % Margin | – | – | – | – |
| Net Income | -$11,894 | -$11,350 | $0 | -$18,268 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.64 | -0.61 | 0 | -3.68 |
| % Growth | -4.9% | – | 100% | – |
| Operating Cash Flow | -$11,333 | -$12,539 | -$7,441 | -$3,567 |
| Capital Expenditures | -$183 | $0 | $0 | $0 |
| Free Cash Flow | -$11,516 | -$12,539 | -$7,441 | -$3,567 |